Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

Published:2005 Issue:8 Volume:52 Page:2263-2271
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Kremer Joel M.,Dougados Maxime,Emery Paul,Durez Patrick,Sibilia Jean,Shergy William,Steinfeld Serge,Tindall Elizabeth,Becker Jean-Claude,Li Tracy,Nuamah Isaac F.,Aranda Richard,Moreland Larry W.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference19 articles.

1. Therapeutic strategies for rheumatoid arthritis

2. Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

3. Studies in B7-Deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis

Cited by 387 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice;Molecular Psychiatry;2024-08-16

2. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06

3. Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study;Seminars in Arthritis and Rheumatism;2024-02

4. Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies;Annals of the Rheumatic Diseases;2023-11-06

5. Targeted Treatment of Diseases of Immune Dysregulation;Rheumatic Disease Clinics of North America;2023-11